NCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
Spruce Biosciences
Corcept Therapeutics
Seoul National University Hospital
Suez Canal University
M.D. Anderson Cancer Center